Cancer BiologybioRxivPreprint
Hitting more birds with one stone: CD70 as an actionable immunotherapeutic target in recurrent glioblastoma
M. Seyfrid, W. Maich, V. M. Shaikh…·S. K. Singh
This study identifies CD70 as a therapeutic target for recurrent glioblastoma, showing that CD70 knockdown reduces tumorigenicity and CD70 CAR-T therapy improves survival in animal models.
DOI 10.1101/2021.06.02.446670